News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
373,343 Results
Type
Article (25657)
Company Profile (66)
Press Release (347620)
Section
Business (104158)
Career Advice (443)
Deals (16860)
Drug Delivery (42)
Drug Development (47479)
Employer Resources (47)
FDA (12223)
Job Trends (8414)
News (185662)
Policy (19378)
Tag
Academia (1730)
Allergies (45)
Alliances (26515)
Alzheimer's disease (713)
Approvals (12178)
Artificial intelligence (76)
Bankruptcy (136)
Best Places to Work (6799)
Breast cancer (81)
Cancer (602)
Cardiovascular disease (63)
Career advice (404)
Cell therapy (106)
Clinical research (39163)
Collaboration (188)
COVID-19 (1445)
C-suite (48)
Data (628)
Diabetes (88)
Diagnostics (3343)
Drug pricing (45)
Earnings (35758)
Employer resources (45)
Events (50223)
Executive appointments (164)
FDA (12587)
Funding (158)
Gene therapy (64)
GLP-1 (309)
Government (2989)
Healthcare (12117)
Infectious disease (1489)
Inflammatory bowel disease (65)
IPO (6964)
Job creations (1836)
Job search strategy (375)
Layoffs (149)
Legal (3611)
Liver cancer (47)
Lung cancer (119)
Manufacturing (57)
Medical device (12674)
Medtech (12677)
Mergers & acquisitions (9952)
Metabolic disorders (232)
Neuroscience (865)
NextGen Class of 2024 (3923)
Non-profit (2811)
Northern California (653)
Obesity (138)
Opinion (60)
Patents (50)
People (34013)
Phase I (11177)
Phase II (16956)
Phase III (13942)
Pipeline (155)
Postmarket research (1665)
Preclinical (3497)
Radiopharmaceuticals (156)
Rare diseases (89)
Real estate (2838)
Regulatory (13618)
Research institute (1596)
Resumes & cover letters (48)
Southern California (589)
Startups (2114)
United States (6702)
Vaccines (281)
Weight loss (103)
Date
Today (114)
Last 7 days (456)
Last 30 days (1755)
Last 365 days (20067)
2024 (17366)
2023 (22736)
2022 (30680)
2021 (32986)
2020 (32197)
2019 (28415)
2018 (21811)
2017 (18906)
2016 (18113)
2015 (21195)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (353)
Arizona (86)
Asia (23978)
Australia (3791)
California (1438)
Canada (712)
China (141)
Colorado (77)
Connecticut (77)
Europe (46766)
Florida (266)
Georgia (62)
Illinois (206)
Indiana (126)
Kansas (67)
Maryland (399)
Massachusetts (1069)
Michigan (59)
Minnesota (168)
New Hampshire (53)
New Jersey (535)
New York (478)
North Carolina (382)
Northern California (653)
Ohio (81)
Pennsylvania (474)
South America (518)
Southern California (589)
Texas (243)
Washington State (126)
373,343 Results for "anamar medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
AnaMar Announces US and EU Orphan Drug Designation for AM1476 for Treating Systemic SclerosisFirst-in-class, peripheral-acting serotonin receptor antagonist being developed as an anti-fibrotic treatment for systemic sclerosis
AnaMar, a clinical-stage biotech company developing first-in-class anti-fibrotic 5-HT2B receptor antagonists, announces that the European Medicines Agency and the United States Food and Drug Administration have granted orphan drug designation to its lead clinical candidate, AM1476 for the treatment of systemic sclerosis.
February 5, 2024
·
4 min read
Drug Development
AnaMar Announces Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis
AnaMar, a clinical-stage biotech company developing a first-in-class, peripheral 5-HT2B receptor antagonist, AM1476, as a pan anti-fibrotic medicine, announces positive results from its Phase I study, and the completion of Phase II enabling pre-clinical studies for its initial orphan indication in systemic sclerosis characterized by lung and skin fibrosis.
May 23, 2023
·
4 min read
Press Releases
Tenon Medical(R) Regains Full Compliance with Nasdaq Continued Listing Requirements
October 28, 2024
·
3 min read
News
Tenon Medical(R) Announces Issuance of Three U.S. Patents
October 18, 2024
·
4 min read
Press Releases
Therma Bright Announces Quantify Medical as Nationwide U.S. Distribution Partner from August 22, 2024 Press Release
Quantify Medical Sees Initial Success with Venowave VW5 Sales and Medicare/Medicaid Reimbursement Test
October 10, 2024
·
6 min read
Press Releases
Neurotech is Changing the Way We Treat Disease and Understand the Brain; Are Our Medical and Legal Institutions Ready?
The Dana Foundation Launches Neurotech Justice Accelerator at Mass General Brigham (NJAM) to Unite Science and Society and Mitigate Medical, Legal, and Ethical Risks
October 4, 2024
·
1 min read
Press Releases
Record Monthly Enrollment Achieved in SeaStar Medical’s Pivotal Adult AKI Trial
November 4, 2024
·
8 min read
Biotech Bay
Journal of Respirology Publishes Clinical Trial Data Demonstrating the Benefits of Noah Medical’s Galaxy System
Medical robotics innovatorNoah Medical today announced the final results from its FRONTIER Study, the platform’s first-in-human clinical trial testing the “Tool-in-Lesion” accuracy of its Galaxy System™, are now available for review in the Official Journal of the Asian Pacific Society of Respirology.
June 27, 2024
·
3 min read
BioCapital
Radon Medical Imaging Announces 5-Year Medical Imaging Asset Management Agreement with Vandalia Health
Radon Medical Imaging, a leading medical imaging equipment maintenance and repair services company, announced it was selected as the Medical Imaging Asset Management firm for several Vandalia Health facilities.
May 16, 2024
·
2 min read
Deals
Tri-Tech expands emergency medical offering with the strategic acquisition of SAM Medical
Tri-Tech Forensics, Inc., a leading provider of tactical emergency medical solutions and human identification kits, is pleased to announce the acquisition of SAM® Medical, a globally renowned provider of innovative medical devices and trauma care solutions including tourniquets, hemostatics, splints, pelvic binders, and intraosseous access systems.
May 8, 2024
·
4 min read
1 of 37,335
Next